[1] Rotman M,Sedlis A,Piedmonte MR,et al. A Phase III randomized trial of postoperative pelvic irradiation in stage ⅠB cervical carcinoma with poor prognostic features:follow-up of a gynecologic oncology group study[J]. Int J Radiat Oncol Biol Phys,2006,65 (1):169-176. [2] Peters WA,Liu PY,Barrett RJ,et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervical[J]. J Clin Oncol,2000, 18 (8):1606-1613. [3] Perry WG. Postoperative irradiation in cervical cancer:prognostic factors and outcome[J]. Radiat Med,2004,22 (2):106–110. [4] 陈 鲁,吕卫国,谢 幸,等. 子宫颈鳞癌Ⅰb期~Ⅱa期期患者预后预测系统的建立及其临床意义[J]. 中华妇产科杂志,2005,40 (4):239-242. [5] 熊 樱,梁立治,刘继红,等. 宫颈鳞癌预后因素的层别化及其临床意义[J]. 中国肿瘤临床,2007,34 (18):148-152. [6] Uno T,Isobe K,Yamamoto S,et al. Postoperative radiation therapy for carcinoma of the uterine cervix[J]. Radiat Med, 2006,24 (2):91-97. [7] 孙建衡. 子宫颈癌治疗的回顾与展望[J]. 中华肿瘤杂志,2006,28 (2):159-160. [8] 尹茳平,李 力. 影响宫颈癌手术疗效临床病理因素的循证评价[J]. 广西医学杂志,2011,33 (10):1262-1266. [9] Liu MT,Hsu JC,Liu WS,et al.Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy[J].Eur J Cancer Care (Engl),2008,17 (2):174-181. [10] 玛 珂,刘桐宇,黄伟萍,等. 手术及术后化疗治疗有复发中危和高危因素的ⅠB-ⅡA期宫颈癌68例疗效分析[J]. 实用妇产科杂志,2012,28 (11):923- 927. [11] Vistad I,Fossa SD,Dahl AA. A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer[J]. Gynecol Oncol,2006,102 (3):563-572. [12] Huang YT,Wang CC,Tsai CS,et al. Clinical behaviors and outcomes for adenocarcinomaor adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy[J]. Int J Radiat Oncol Biol Phys,2012, 84 (2):420-427. [13] 杨凌云,王红静,贾西彪,等. 35岁以下年轻宫颈癌患者临床病理特征及预后分析[J]. 广东医学,2012,33 (18): 2802-2804. |